Autopsy Validation of the Diagnostic Accuracy of (123)I-Metaiodobenzylguanidine Myocardial Scintigraphy for Lewy Body Disease

BACKGROUND AND OBJECTIVES: (123)I-meta-iodobenzyl-guanidine ((123)I-MIBG) myocardial scintigraphy is used as a diagnostic imaging test to differentiate Lewy body diseases (LBDs), including Parkinson disease and dementia with Lewy bodies, from other similar diseases. However, this imaging test lacks...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsubara, Tomoyasu, Kameyama, Masashi, Tanaka, Noriko, Sengoku, Renpei, Orita, Makoto, Furuta, Ko, Iwata, Atsushi, Arai, Tomio, Maruyama, Hirofumi, Saito, Yuko, Murayama, Shigeo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052572/
https://www.ncbi.nlm.nih.gov/pubmed/35256483
http://dx.doi.org/10.1212/WNL.0000000000200110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052572/
https://www.ncbi.nlm.nih.gov/pubmed/35256483
http://dx.doi.org/10.1212/WNL.0000000000200110

Ejemplares similares